Literature DB >> 33845007

Classification Criteria for Fuchs Uveitis Syndrome.

.   

Abstract

PURPOSE: To determine classification criteria for Fuchs' uveitis syndrome.
DESIGN: Machine learning of cases with Fuchs' uveitis syndrome and 8 other anterior uveitides.
METHODS: Cases of anterior uveitides were collected in an informatics-designed preliminary database, and a final database was constructed of cases achieving supermajority agreement on the diagnosis, using formal consensus techniques. Cases were split into a training set and a validation set. Machine learning using multinomial logistic regression was used on the training set to determine a parsimonious set of criteria that minimized the misclassification rate among the anterior uveitides. The resulting criteria were evaluated on the validation set.
RESULTS: One thousand eighty-three cases of anterior uveitides, including 146 cases of Fuchs' uveitis syndrome, were evaluated by machine learning. The overall accuracy for anterior uveitides was 97.5% in the training set and 96.7% in the validation set (95% confidence interval 92.4, 98.6). Key criteria for Fuchs' uveitis syndrome included unilateral anterior uveitis with or without vitritis and either: 1) heterochromia or 2) unilateral diffuse iris atrophy and stellate keratic precipitates. The misclassification rates for Fuchs' uveitis syndrome were 4.7% in the training set and 5.5% in the validation set, respectively.
CONCLUSIONS: The criteria for Fuchs' uveitis syndrome had a low misclassification rate and appeared to perform well enough for use in clinical and translational research.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33845007      PMCID: PMC8594748          DOI: 10.1016/j.ajo.2021.03.052

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.488


  20 in total

1.  Cataract extraction outcomes in patients with Fuchs' heterochromic cyclitis.

Authors:  Sushma Tejwani; Somasheila Murthy; Virender S Sangwan
Journal:  J Cataract Refract Surg       Date:  2006-10       Impact factor: 3.351

2.  Cytomegalovirus anterior uveitis: outcome of treatment.

Authors:  S-P Chee; A Jap
Journal:  Br J Ophthalmol       Date:  2010-06-24       Impact factor: 4.638

3.  Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience.

Authors:  Douglas A Jabs; Andrew Dick; John T Doucette; Amod Gupta; Susan Lightman; Peter McCluskey; Annabelle A Okada; Alan G Palestine; James T Rosenbaum; Sophia M Saleem; Jennifer Thorne; Brett Trusko
Journal:  Am J Ophthalmol       Date:  2017-11-06       Impact factor: 5.258

4.  The diagnostic utility of anterior chamber paracentesis with polymerase chain reaction in anterior uveitis.

Authors:  Zane Anwar; Anat Galor; Thomas A Albini; Darlene Miller; Victor Perez; Janet L Davis
Journal:  Am J Ophthalmol       Date:  2013-02-12       Impact factor: 5.258

5.  Fuchs' heterochromic cyclitis: a post-infectious manifestation of ocular toxoplasmosis?

Authors:  Akesbi Jad; Terrada Céline; Bodaghi Bahram; LeHoang Phuc; Cassoux Nathalie
Journal:  Int Ophthalmol       Date:  2012-10-16       Impact factor: 2.031

6.  Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs' heterochromic cyclitis.

Authors:  Peter C Ruokonen; Sylvia Metzner; Aylin Ucer; Necip Torun; Jörg Hofmann; Uwe Pleyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-04       Impact factor: 3.117

7.  Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor.

Authors:  Claus D Quentin; Hansotto Reiber
Journal:  Am J Ophthalmol       Date:  2004-07       Impact factor: 5.258

8.  Fuchs' heterochromic cyclitis and ocular toxoplasmosis.

Authors:  M Toledo de Abreu; R Belfort; P S Hirata
Journal:  Am J Ophthalmol       Date:  1982-06       Impact factor: 5.258

9.  Presumed fuchs heterochromic iridocyclitis and Posner-Schlossman syndrome: comparison of cytomegalovirus-positive and negative eyes.

Authors:  Soon-Phaik Chee; Aliza Jap
Journal:  Am J Ophthalmol       Date:  2008-12       Impact factor: 5.258

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

View more
  5 in total

1.  Contrast Sensitivity Deficits and Its Structural Correlates in Fuchs Uveitis Syndrome.

Authors:  Fang-Yue Zhou; Yi-Sha Li; Xingneng Guo; Xiutong Shi; Ke Wu; Jing-Wei Zheng; Xia-Xin Li; Jiaqing Wu; Ruru Liu; Ma-Li Dai; Xiu-Feng Huang; Fang Hou; Dan Lin; Yu-Qin Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-19

Review 2.  [Development of classification criteria for uveitis by the standardization of uveitis nomenclature (SUN) working group].

Authors:  Arnd Heiligenhaus; Kai Rothaus; Uwe Pleyer
Journal:  Ophthalmologe       Date:  2021-08-30       Impact factor: 1.059

3.  Aqueous Humor Analysis in Overlapping Clinical Diagnosis of Cytomegalovirus and Rubella Virus Anterior Uveitis.

Authors:  Fabrizio Gozzi; Lucia Belloni; Raffaella Aldigeri; Pietro Gentile; Valentina Mastrofilippo; Luca De Simone; Elena Bolletta; Federica Alessandrello; Martina Bonacini; Stefania Croci; Alessandro Zerbini; Gian Maria Cavallini; Carlo Salvarani; Luca Cimino
Journal:  Medicina (Kaunas)       Date:  2022-08-04       Impact factor: 2.948

4.  Editorial: Multimodal imaging in uveitis.

Authors:  Alex Fonollosa; Ester Carreño; Aniruddha Agarwal
Journal:  Front Med (Lausanne)       Date:  2022-09-02

5.  Factors associated with low prevalence of Fuchs' uveitis syndrome in Japan.

Authors:  Yu Yoneda; Yoshihiko Usui; Rie Tanaka; Keitaro Hase; Kenichi Namba; Koju Kamoi; Hiroshi Takase; Masaki Takeuchi; Wataru Matsumiya; Sentaro Kusuhara; Atsunobu Takeda; Nobuyo Yawata; Ryoji Yanai; Tomona Hiyama; Yosuke Harada; Noriyasu Hashida; Kazuichi Maruyama; Kei Nakai; Ryo Taguchi; Toshikatsu Kaburaki; Nobuhisa Mizuki; Hiroshi Goto; Yujiro Fujino; Masaru Takeuchi
Journal:  Front Med (Lausanne)       Date:  2022-09-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.